SUSPENSION OF EXECUTIVE DIRECTOR Cipla Medpro South Africa Limited (Incorporated in the Republic of South Africa) (Registration number 2002/018027/06) Share code: CMP ISIN: ZAE000128179 (the "Company" or “Cipla Medpro”) SUSPENSION OF EXECUTIVE DIRECTOR The Board of Cipla Medpro (the “Board”) regrets to inform shareholders that at the meeting of the Board held on 14 August 2012 the Board resolved to undertake a full investigation into serious allegations concerning its Chief Executive Officer (“CEO”), Mr Jerome Smith. Shareholders can rest assured the Board did not take this step lightly and without very long, careful and considered thought. Pursuant to this decision, Mr Smith has been suspended with effect from 15 August 2012 pending the outcome of the investigation. The Board has appointed Mr Johan du Preez as acting CEO for the duration of Mr Smith’s suspension. Mr du Preez currently serves on the Board as an independent non-executive director. He has a MPharm from the University of Pretoria, as well as a MBA from the National University in San Diego, California. Mr du Preez has a wealth of extensive corporate experience having previously held the positions of CEO of ADATO Capital, Glacier by Sanlam (previously called Innofin) and Sanlam Health, Mr du Preez is the founder and managing director of SAAD Investment Holdings , an investment company primarily focusing on establishing new financial services entities. He has been involved in various industries locally and in the USA, including Pharmaceutical Retail, Medical Insurance & Risk Management, Investment Management, Life Insurance and Financing. The Board has full confidence that Mr du Preez is best placed to execute this interim office in the circumstances so that the business of the Company will continue as usual during the investigation and in a manner designed to minimise the impact on day to day operations. The Board will take all steps open to it to endeavour to ensure that the investigation will be completed as quickly as possible and will continuously monitor the operations of the Company. Shareholders are invited to direct any queries which they may have only to the Chairman of the Board, Mr Sbu Luthuli. Further announcements will be made by the Board as appropriate from time to time. The results of the Company will be released on SENS on 16 August 2012 as originally scheduled. Durban 15 August 2012 Sponsor Nedbank Capital Date: 15/08/2012 05:08:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.